AGE1
Age1 is a venture capital firm that primarily invests in biotechnology companies. The firm is driven by a vision to make aging and age-related diseases optional for all.
AGE1
Social Links:
Industry:
Biotechnology Business Development
Founded:
2023-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Nginx U.S. Server Location AWS Global Accelerator Express Browse Happy
Similar Organizations
Genoa Ventures
Genoa Ventures is a venture capital firm that invests in early-stage life sciences technology companies.
Accomplice
Accomplice is a seed-led venture capital firm that primarily invests in technology startup companies.
Atom Bioscience & Pharmaceutical
Atom Bioscience is a clinical-stage biotechnology company.
Catalio Capital Management
Catalio Capital Management is a Venture capital investments in breakthrough biomedical technology companies.
Dimension Therapeutics
Dimension Therapeutics is a gene therapy company developing novel treatments for rare diseases.
G Squared
G Squared is a growth stage venture capital firm that invests privately in today's most dynamic companies.
Owl Ventures
Owl Ventures is a venture capital fund that invests in education technology companies.
Peroxitech Therapeutics
Peroxitech Therapeutics operates as a biopharmaceutical company.
Stabiliz Orthopaedics
Stabiliz Orthopaedics develops novel enhancements for orthopedic medical devices using FDA-approved technologies.
Current Advisors List
Current Employees Featured
More informations about "age1"
age1 - LinkedIn
Age1 | 1,239 followers on LinkedIn. Early backer of breakthrough, founder-led longevity companies | age1 funds breakthrough longevity companies addressing the core challenges of the field. We help ...See details»
age1 - YouTube
A first of a kind venture capital fund focused on longevity, run by experts in aging biology; age1 catalyzes contrarian, founder-led companies that will increase healthy human lifespan, yielding ...See details»
age1 - Crunchbase Investor Profile & Investments
Age1 is a venture capital firm that primarily invests in biotechnology companies. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ... 4,791 โฆSee details»
age1 launches with $35 million to extend healthy lifespan
Sep 19, 2023 Now age1 feels the longevity biotech industry is on the brink of a similar regulatory milestone in human clinical trials. โage1 is the next chapter in The Longevity Fundโs mission and the inflection point for the field,โ said Laura โฆSee details»
โWe are so close to the future we wantโ
Oct 4, 2023 Last month, we covered the launch of age1, a San Francisco VC firm on a mission to lead investments in longevity science moonshots, catalyze the next generation of founder-led longevity biotech companies and advance โฆSee details»
age1 - Emerging Manager Monthly
Age1 is a biotech VC firm that funds healthy lifespan extension. Its predecessor fund is Longevity Fund, the first longevity-focused fund (5 IPOs w/ $1B raised in follow-on cap) founded by age1 โฆSee details»
Dr. Alex Colville, Ph.D. - Co-Founder and General โฆ
Oct 3, 2023 Dr. Alex Colville, Ph.D. is Co-Founder and General Partner of age1 ( https://age1.com/ ), a venture capital firm focused on catalyzing the next generation of...See details»
age1 - Investments, Portfolio & Company Exits - Crunchbase
Feb 1, 2024 age1 has invested in Aperture Therapeutics on Feb 1, 2024. How many investments has this organization made over time? Show . Which industries has this โฆSee details»
age1 Launches to Advance The Longevity Fundโs Mission to โฆ
Sep 19, 2023 About age1 age1 is a venture capital firm that funds healthy lifespan extension. Built on the foundation of The Longevity Fund, age1 is extending its decade of expertise to โฆSee details»
Venture Capital Firm age1 Raises $35M to Advance Longevity โฆ
Jun 13, 2023 age1, a venture capital firm specializing in longevity biotech, launched earlier this week in San Francisco announcing an initial closing fund of $35M.The firm aims to radically โฆSee details»
age1 Overview | SignalHire Company Profile
Age1 Overview Contact top employees from age1 Summary. age1 funds breakthrough longevity companies addressing the core challenges of the field. ... Organization Website. age1.com . โฆSee details»
age1 Closes $35 Million To Invest In Longevity Biotech Companies
Sep 28, 2023 age1 - a VC firm catalyzing the next generation of founder-led longevity biotech companies - recently launched to build a community of visionaries advancing new โฆSee details»
age1 - Contacts, Employees, Board Members, Advisors & Alumni
Age1 is a venture capital firm that primarily invests in biotechnology companies.See details»
Libraries for the Future | age1 | Substack
Dear Founders: age1โs 2024 wishlist for new companies to unlock healthy longevity for all We want exceptional founders to work on achieving healthy lifespan extension within the next โฆSee details»
Maggie L. - Venture - age1 | LinkedIn
Bioengineering · Interested in tissue engineering, biophysics, and aging biology. Personal website: maggiezli.com.<br><br>Grateful for support from the Masason Foundation, โฆSee details»
HelpAge Canada | Helping older persons live with dignity in โฆ
In 1975, a group of volunteers, concerned that no Canadian charitable organization represented the interests and needs of older persons in Canada, came together to found โHelp the Aged โฆSee details»
Home | CanAge
Sep 12, 2023 Advocacy Organization. A Trusted Voice of Canadian Seniors Explore Partnership Opportunities. Vaccine Report 2022-23. Despite good intentions and promising strategies, โฆSee details»
Age-Friendly Communities in Canada: Community Implementation โฆ
As Canada's population ages, it is especially important to support older Canadians in the places where they live. Making communities age-friendly holds promise as an effective way to help โฆSee details»
Here Are the Age Ranges for Millennials, Gen Z, and Gen Alpha
Feb 22, 2024 The organization cites important political, economic, and technological factors that helped them determine the cutoff from Millennial to Gen Z. Most American Millennials were โฆSee details»
Mean fasting blood glucose - World Health Organization (WHO)
The expected values for normal fasting blood glucose concentration are between 70 mg/dL (3.9 mmol/L) and 100 mg/dL (5.6 mmol/L). When fasting blood glucose is between 100 to 125 โฆSee details»